Contact Information
Company Information
Company
Shanghai Allist Pharmaceuticals Co., Ltd
Total Funding
171000000.0
Technologies
Microsoft Office 365
Mobile Friendly
Remote
Keywords
pharmaceutical manufacturing
biopharmaceutical
tumor treatment
oncology
egfr
kras
pd-l1
furmonertinib
drug discovery
clinical trials
innovative medicines
first-in-class
best-in-class
cancer therapy
small molecule
non-small cell lung cancer
intellectual property
research & development
medical innovations
drug approval
clinical study
oral medications
drug pipeline
global synchronization
emerging therapies
market analysis
healthcare solutions
collaborations
scalable manufacturing
patient-centered
precision medicine
investor relations
pharmaceutical market
r&d center
scientific leadership
translational medicine
regulatory compliance
medicine commercialization
healthcare advancements
technology transfer
clinical efficacy
strategic partnerships
advanced drug formulations
safety & efficacy
long-term care solutions
biomarker development
industry standards
healthcare equity
patient outcomes
scientific innovation
pharmaceuticals
medical
hospital & health care
health care
health
wellness & fitness
Get Full Contact Details
Subscribe to reveal email addresses and export contacts.
View Plans